Brighton Jones LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Sell |
4,559
-1,862
| -29% | -$829K | 0.06% | 190 |
|
|
2025
Q1 | $3.11M | Buy |
6,421
+1,994
| +45% | +$967K | 0.1% | 119 |
|
|
2024
Q4 | $1.78M | Buy |
4,427
+579
| +15% | +$233K | 0.05% | 181 |
|
|
2024
Q3 | $1.79M | Sell |
3,848
-452
| -11% | -$210K | 0.07% | 144 |
|
|
2024
Q2 | $2.02M | Buy |
4,300
+3,171
| +281% | +$1.49M | 0.07% | 150 |
|
|
2024
Q1 | $472K | Buy |
1,129
+194
| +21% | +$81.1K | 0.02% | 360 |
|
|
2023
Q4 | $380K | Sell |
935
-129
| -12% | -$52.5K | 0.02% | 387 |
|
|
2023
Q3 | $370K | Buy |
1,064
+45
| +4% | +$15.6K | 0.02% | 353 |
|
|
2023
Q2 | $359K | Buy |
1,019
+60
| +6% | +$21.1K | 0.02% | 363 |
|
|
2023
Q1 | $302K | Buy |
959
+85
| +10% | +$26.8K | 0.02% | 374 |
|
|
2022
Q4 | $252K | Sell |
874
-369
| -30% | -$107K | 0.02% | 379 |
|
|
2022
Q3 | $360K | Buy |
1,243
+369
| +42% | +$107K | 0.02% | 300 |
|
|
2022
Q2 | $246K | Buy |
874
+29
| +3% | +$8.16K | 0.01% | 374 |
|
|
2022
Q1 | $221K | Buy |
+845
| New | +$221K | 0.01% | 453 |
|